What are the recommended cough suppressants for influenza (influenza virus infection)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2025 • View editorial policy

From the Guidelines

Cough suppressants are generally not recommended for influenza as coughing is a protective mechanism that helps clear mucus and infectious particles from the respiratory tract. However, if a cough is severe and interfering with sleep or daily activities, short-term use of certain suppressants may be appropriate. The most recent and highest quality study on the topic of cough management in influenza does not specifically address cough suppressants, but rather focuses on antiviral treatment and chemoprophylaxis 1. Given the lack of direct evidence on cough suppressants for influenza, we can look at general guidelines for cough management. Dextromethorphan (found in products like Robitussin DM or Delsym) at 30mg every 6-8 hours for adults can help suppress coughing, as it is a central cough suppressant with some efficacy in acute cough 2. For nighttime relief, products containing both dextromethorphan and an antihistamine like diphenhydramine (such as NyQuil) may be more effective. These should only be used for 3-5 days maximum. Codeine-based suppressants are stronger but require prescriptions in many places and carry risks of dependence. Instead of suppressants, better options for managing influenza cough include:

  • Staying hydrated
  • Using honey (1-2 teaspoons as needed for adults, not for children under 1 year)
  • Throat lozenges
  • Humidifiers
  • Treating the underlying influenza with rest and appropriate antiviral medications if prescribed, such as oseltamivir or zanamivir 3, 1. Cough suppressants only mask symptoms without addressing the viral infection itself, and overuse can lead to complications by preventing the clearing of respiratory secretions. It's essential to prioritize treating the underlying cause of the cough, which in this case is the influenza virus, rather than just managing the symptom of coughing.

From the FDA Drug Label

Oseltamivir phosphate for oral suspension is indicated for the treatment of influenza A and B in patients 2 weeks of age or older.

The recommended cough suppressants for influenza are not mentioned in the drug label. Oseltamivir is an antiviral medication, not a cough suppressant. The FDA drug label does not answer the question.

From the Research

Cough Suppressants for Influenza

The provided studies do not directly address the recommended cough suppressants for influenza. However, some studies mention the treatment of influenza and its symptoms.

  • The studies 4, 5, 6 discuss the use of neuraminidase inhibitors, such as zanamivir and oseltamivir, for the treatment and prevention of influenza.
  • These studies do not specifically mention cough suppressants, but rather focus on the antiviral treatment of influenza.
  • Study 7 discusses cough suppressants for chronic cough, but not specifically for influenza.
  • Study 8 examines the effectiveness of three cough syrups, including codeine and dextromethorphan, but does not focus on influenza.

Available Cough Suppressants

Some available cough suppressants mentioned in the studies include:

  • Centrally acting opioids, such as morphine, codeine, and dextromethorphan 7
  • Peripherally acting antitussives, such as moguisteine and levodropropizine 7
  • Guaifenesin, which was compared to guaifenesin plus codeine or guaifenesin plus dextromethorphan in study 8

Limitations

The provided studies do not provide a clear answer to the question of recommended cough suppressants for influenza, as they focus on antiviral treatment or chronic cough rather than acute cough associated with influenza.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.